AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (Q2043834)

From EU Knowledge Graph
Revision as of 23:58, 24 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations)
Jump to navigation Jump to search
Project Q2043834 in Italy
Language Label Description Also known as
English
AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING
Project Q2043834 in Italy

    Statements

    0 references
    15,000.0 Euro
    0 references
    30,000.0 Euro
    0 references
    50.0 percent
    0 references
    25 October 2017
    0 references
    15 October 2018
    0 references
    30 December 2019
    0 references
    ARDIS S.R.L.
    0 references
    0 references

    45°11'9.60"N, 9°9'16.70"E
    0 references
    AN INNOVATIVE TECHNOLOGY PLATFORM FOR THE DEVELOPMENT AND COMMERCIALISATION OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY PRE-TREATMENT DIAGNOSTIC TESTING (Italian)
    0 references
    AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (English)
    0 references
    UNE PLATE-FORME TECHNOLOGIQUE INNOVANTE POUR LE DÉVELOPPEMENT ET LA COMMERCIALISATION DE TRAITEMENTS ANTICANCÉREUX À BASE D’ANTICORPS SOUTENUS PAR DES TESTS DIAGNOSTIQUES PRÉ-TRAITEMENT (French)
    16 December 2021
    0 references
    EEN INNOVATIEF TECHNOLOGIEPLATFORM VOOR DE ONTWIKKELING EN COMMERCIALISERING VAN ANTILICHAAMGEBASEERDE KANKERTHERAPIEËN ONDERSTEUND DOOR DIAGNOSTISCHE TESTS VOOR DE BEHANDELING (Dutch)
    23 December 2021
    0 references
    EINE INNOVATIVE TECHNOLOGIEPLATTFORM ZUR ENTWICKLUNG UND KOMMERZIALISIERUNG VON ANTIKÖRPER-BASIERTEN KREBSTHERAPEUTIKA, UNTERSTÜTZT DURCH VORBEHANDLUNGSDIAGNOSTIK (German)
    24 December 2021
    0 references
    UNA PLATAFORMA TECNOLÓGICA INNOVADORA PARA EL DESARROLLO Y COMERCIALIZACIÓN DE TERAPIAS CONTRA EL CÁNCER BASADAS EN ANTICUERPOS, RESPALDADA POR PRUEBAS DIAGNÓSTICAS PREVIAS AL TRATAMIENTO (Spanish)
    25 January 2022
    0 references

    Identifiers

    E17F17000030002
    0 references